ISRCTN44725655已完成不适用
Comparison of Second-Line Hormonal Agents Medroxyprogesterone Acetate and Aminoglutethimide in Advanced Breast Cancer
Ciba-Geigy Pharmaceuticals (Switzerland)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Advanced breast cancer
- •2. Relapsed or failed following tamoxifen treatment
- •3. Postmenopausal
排除标准
- •Not provided at time of registration.
研究者
相似试验
招募中
1 期
Comparison of the effect of medroxyprogesterone acetate and black seed extract on the symptoms of polycystic ovary syndrome in adolescent girlsPolycystic ovary syndrome.Polycystic ovarian syndromeE28.2IRCT20221017056209N1Gonabad University of Medical Sciences116
招募中
3 期
Comparison of the effects of medroxyprogestron and megestrol on vasomotor symptom in menopause womeIRCT20210412050945N1Karaj University of Medical Sciences80
尚未招募
2 期
Comparing ormeloxifene (a contraceptive) and medroxyprogesterone acetate (hormone supplement) in heavy periods patientsCTRI/2024/01/061782Sri manakula vinayagar medical college and hospital
已完成
3 期
Medroxyprogesterone acetate and dydrogesterone effect in the treatment of uterine bleedingIRCT20140111016161N7Tehran University of Medical Sciences176
尚未招募
4 期
Comparing the effect of depo-medroxyprogesterone acetate (DMPA) and bromocriptine in women with symptomatic myoma uteri: a randomized controlled trialSymptomatic myoma uteriMyoma uteriTCTR20200714001none126